Skip to main content
TipRanks
Go Ultimate75% OFF

HOYA (HYB0) AI Stock Analysis

1 Followers
DE:HYB0

HOYA

(Frankfurt:HYB0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
High ProfitabilityHOYA’s exceptionally high gross, operating, and net margins indicate strong product differentiation and pricing power across its optical, medical, and precision technology businesses. This profitability provides resilience against cost pressure and creates substantial capacity to fund innovation, investment, and shareholder returns.
Negative Factors
Slowing Revenue GrowthRecent top-line deceleration could limit the pace of future earnings expansion if HOYA cannot offset slower demand with new products, volume growth, or further pricing. Sustained margin strength remains valuable, but a weaker revenue engine may make long-term profit growth increasingly dependent on efficiency and mix.

HOYA (HYB0) vs. iShares MSCI Germany ETF (EWG)

-5%0%5%10%15%20%25%30%DE:HYB0+4.48%EWG+9.26%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 48.73B
Dividend Yield
1.34%
Average Volume (3M)
45
Price to Earnings (P/E)
27.8
Beta (1Y)
0.84
Revenue Growth
1.85%
EPS Growth
24.77%
Country
Germany
Employees
37,752
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

HOYA Business Overview & Revenue Model

Company Description

Established in Tokyo, Japan, in 1941, HOYA Corporation operates as a global med-tech enterprise and a leading provider of advanced technological and medical solutions. Its extensive "life care" division offers a diverse portfolio, ranging from ophtha...

HOYA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:HYB0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ISRGISRG84Outperform$151.74B52.4217.03%―20.45%8.75%
BLCOBLCO65Neutral$7.46B-67.65-1.73%―8.88%63.73%
BDXBDX63Neutral$58.96B52.244.64%1.84%-7.40%-28.89%
STAASTAA59Neutral$1.31B2581.000.15%―42.36%―
COOCOO57Neutral$11.77B21.226.88%―4.73%43.89%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-40%-20%0%20%40%DE:HYB0BDXCOOISRGSTAABLCODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:HYB0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:HYB0Hoya Corp131.006.625.32%
BDXBecton, Dickinson and Co216.4769.8747.66%
COOCooper Companies61.88-10.27-14.23%
ISRGIntuitive Surgical437.75-126.89-22.47%
STAAStaar Surgical Company26.01-0.44-1.66%
BLCOBausch + Lomb Corporation20.886.2642.82%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.